Détail de l'auteur
Auteur L. DEGENHARDT |
Documents disponibles écrits par cet auteur (103)
Article : Périodique
P. K. NELSON ; B. M. MATHERS ; B. COWIE ; H. HAGAN ; D. C. DES JARLAIS ; D. HORYNIAK ; L. DEGENHARDT |BACKGROUND: Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the issue do not exist. We estimated national, regional, and global prevalence and population siz[...]Périodique
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
B. M. MATHERS ; L. DEGENHARDT ; B. PHILLIPS ; L. WIESSING ; M. HICKMAN ; S. A. STRATHDEE ; A. WODAK ; PANDA S. ; M. TYNDALL ; A. TOUFIK ; R. P. MATTICK | 2008ENGLISH : BACKGROUND: Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among peo[...]Article : Périodique
J. LEUNG ; A. PEACOCK ; S. COLLEDGE ; J. GREBELY ; E. B. CUNNINGHAM ; M. HICKMAN ; P. VICKERMAN ; J. STONE ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; L. HINES ; P. GRIFFITHS ; R. P. MATTICK ; L. DEGENHARDT ; S. LARNEY |BACKGROUND: Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses (BBVs), but gender-based differences in BBV prevalence have not been systematically examined. MET[...]Article : Périodique
L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY |We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]Article : Périodique
L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY |Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]Article : Périodique
S. LARNEY ; A. PEACOCK ; J. LEUNG ; S. COLLEDGE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY ; K. V. DUMCHEV ; P. GRIFFITHS ; L. HINES ; E. B. CUNNINGHAM ; R. P. MATTICK ; M. LYNSKEY ; J. MARSDEN ; J. STRANG ; L. DEGENHARDT |Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution ther[...]Article : Périodique
J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT |BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]Article : Périodique
A. PEACOCK ; J. LEUNG ; S. LARNEY ; S. COLLEDGE ; M. HICKMAN ; J. REHM ; G. A. GIOVINO ; R. WEST ; W. HALL ; P. GRIFFITHS ; R. ALI ; L. GOWING ; J. MARSDEN ; A. J. FERRARI ; J. GREBELY ; M. FARRELL ; L. DEGENHARDT |AIMS: This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addresse[...]Article : Périodique
G. C. PATTON ; C. COFFEY ; C. CAPPA ; D. CURRIE ; L. RILEY ; F. GORE ; L. DEGENHARDT ; D. RICHARDSON ; N. M. ASTONE ; A. O. SANGOWAWA ; A. MOKDAD ; J. FERGUSON |Adolescence and young adulthood offer opportunities for health gains both through prevention and early clinical intervention. Yet development of health information systems to support this work has been weak and so far lagged behind those for ear[...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; H. ALI ; L. WIESSING ; M. HICKMAN ; R. P. MATTICK ; B. MYERS ; A. AMBEKAR ; S. A. STRATHDEE ; Reference Group to the UN on HIV and Injecting Drug Use |Background: Previous reviews have examined the existence of HIV prevention, treatment, and care services for injecting drug users (IDUs) worldwide, but they did not quantify the scale of coverage. We undertook a systematic review to estimate nat[...]Article : Périodique
D. HORYNIAK ; M. STOOVE ; L. DEGENHARDT ; C. AITKEN ; T. KERR ; P. DIETZE |Background: Changes in drug market characteristics have been shown to affect drug use patterns but few studies have examined their impacts on injecting initiation experiences and subsequent patterns of injecting drug use (IDU). Methods: We coll[...]Article : Périodique
BACKGROUND: In early 2001 Australia experienced a sudden reduction in the availability of heroin which had widespread effects on illicit drug markets across the country. The consequences of this event, commonly referred to as the Australian 'her[...]Article : Périodique
L. T. TRAN ; A. PEACOCK ; S. COLLEDGE ; S. MEMEDOVIC ; J. GREBELY ; J. LEUNG ; S. LARNEY ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; M. HICKMAN ; L. DEGENHARDT |Background: Injecting risk behaviour, such as receptive sharing of injecting equipment and/or re-using one's equipment, is associated with bloodborne virus transmission and infections in people who inject drugs (PWID). We aimed to estimate preva[...]Article : Périodique
E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY |Background: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]Article : Périodique
FRANÇAIS : Objectif : Évaluer si l'usage du cannabis à l'adolescence et au jeune âge adulte est une cause concourante de la psychose schizophréniforme, en ce qu'il peut précipiter la psychose chez les personnes vulnérables. Méthode : Nous avo[...]Périodique
M. T. LYNSKEY ; C. COFFEY ; L. DEGENHARDT ; J. B. CARLIN ; G. PATTON | 2003FRANÇAIS : Cette étude prospective australienne en population générale auprès de 1601 adolescents âgés de 15 à 21 ans a collecté par questionnaire des données sur la consommation hebdomadaire de cannabis et sur le cursus scolaire, notamment sur[...]Article : Périodique
Article : Périodique
FRANÇAIS : Commentaires généraux à partir des résultats du rapport de Hickman et al. (2003, Royaume-Uni - cf. pp.419-425) sur l'évolution des décès liés à la méthadone ou à l'héroïne, sur l'accès au traitement et les risques d'overdoses.Article : Périodique
L. DEGENHARDT ; J. SINGLETON ; B. CALABRIA ; J. MCLAREN ; T. KERR ; S. MEHTA ; G. KIRK ; W. D. HALL |Aims To conduct a systematic review of mortality among cohort studies of cocaine users. Methods Three electronic databases were searched (EMBASE, Medline and PsychINFO); other online databases were searched using online libraries and repositori[...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; C. BUCELLO ; J. LEMON ; L. WIESSING ; M. HICKMAN |FRANÇAIS : Objectif : Examiner systématiquement les études de cohortes de la mortalité chez les toxicomanes par injection, étudier les taux de mortalité et les causes de décès dans ce groupe, et identifier les variables, au niveau des participa[...]Article : Périodique
L. DEGENHARDT ; C. BUCELLO ; B. MATHERS ; C. BRIEGLEB ; H. ALI ; M. HICKMAN ; J. MCLAREN |AIMS: To review the literature on mortality among dependent or regular users of opioids across regions, according to specific causes, and related to a number of demographic and clinical variables. METHODS: Multiple search strategies included sea[...]Livre
S. DARKE ; L. DEGENHARDT ; R. MATTICK | Cambridge - New York : Cambridge University Press | International Research Monographs in the Addictions (IRMA) | 2006ENGLISH : Over the past 40 years the rate of illicit drug use worldwide has risen dramatically, and with it the number of deaths reported among drug-using populations. What are the clinical, ethical and psychopathological implications of these[...]Article : Périodique
L. SORDO ; G. BARRIO ; M. J. BRAVO ; B. I. INDAVE ; L. DEGENHARDT ; L. WIESSING ; M. FERRI ; R. PASTOR-BARRIUSO |Objective: To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of mortality after initiation and ces[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]